PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver - Pediatric
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Drug Studies
Contact Us
Log In
You need to enable JavaScript to run this app page.
Liver - Pediatric
TCH-HB05
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: TCH-HB05
Contact Model Developer
Model Contact
Model: TCH-HB05
Model Contact: Sarah Woodfield
Institution: TCH Liver PDX Program
Email:
sewoodfi@texaschildrens.org
Patient Information
Clinical Timeline
Color Keys:
Unknown
None
Low
Moderate
High
Very High
Clinical Information at Collection
Pathology Information at Collection
Model Information for Model: TCH-HB05
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Mutations (Cancer Gene Census List)
Mutation data is currently not available.
CNV
There are no omics data for this model.
Histology Information for Model: TCH-HB05
There are no histology images for this model.
Metastasis Information for Model: TCH-HB05
Patient
PDX
Lung
Patient Treatment Information for Model: TCH-HB05
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
15
Cisplatin, 5-Fluorouracil/Vincristine
Neoadjuvant
2.33
2.37
15 days
Partial Response
Partial Response
25
Cisplatin, 5-Fluorouracil/Vincristine
Adjuvant
2.42
2.54
44 days
Partial Response
Partial Response
AFP 471
35
Off Therapy Follow-up
Adjuvant
2.6
2.7
37 days
Partial Response
AFP 47.5
Please wait...
